Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA topoisomerase 1 (Top1) is an essential nuclear enzyme that regulates DNA topology by inducing transient single-strand breaks, allowing DNA to rotate and relieve torsional strain during replication and transcription (NIH, 2020). The Top1-DNA cleavage complex (Top1cc) is the catalytic intermediate where the enzyme is covalently attached to the 3-prime phosphate end of the DNA (MDPI, 2020). This complex is the primary molecular target for anticancer agents known as Top1 poisons, such as irinotecan and topotecan, which act as interfacial inhibitors by binding at the enzyme-DNA interface to stabilize the Top1cc (NIH, 1998; AACR, 2020). Stabilization prevents DNA religation, leading to lethal double-strand breaks when replication forks or transcription complexes collide with the trapped enzyme (Wikipedia, 2020). Beyond cancer, Top1 is a target of autoantibodies in systemic sclerosis, indicating its role in autoimmune pathology (NIH, 2020). Clinical response to Top1 inhibitors is often influenced by biomarkers like SLFN11 expression and the activity of repair enzymes such as TDP1 (AACR, 2020). However, these therapies are associated with significant safety concerns, including severe gastrointestinal toxicity and myelosuppression (NIH, 2020).
Interfacial inhibition; stabilization of the covalent Top1-DNA cleavage complex (Top1cc), preventing DNA religation and leading to replication-mediated double-strand breaks.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA topoisomerase 1 - DNA cleavage complex (Top1cc).